Turn Therapeutics

Update in progress

TTRX (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Turn Therapeutics Inc. is a pharmaceuticals company developing drugs for skin, nails, and eye conditions. Its delivery technology penetrates the skin and nails and supports antibiotic stewardship through acute and chronic wound care products. The company serves healthcare institutions for a range of skin issues, from wounds to dermatoses. Formerly Global Health Solutions, Inc, it changed its name in September 2025. Founded in 2015, based in Westlake Village, California.

Company score

Sentiment: 0.41; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.14; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.11; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.24; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive